23 /100
LOW RISK
Score updated May 29, 2026

CYCN — Cyclerion Therapeutics, Inc. Dilution Risk Tracker

Track CYCN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CYCN — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
40
📊 Float Risk
12
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CYCN.
🔔 Track CYCN — Get forecast alerts →

💹 Market Data

Market Cap$13.77M
Shares Outstanding4.33M
Float3.58M
Cash$2.82M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 295.2K shares
#1 Siren, L.L.C. 115.6K shares
#2 Geode Capital Management, LLC 43.3K shares
#3 Two Sigma Investments, LP 41.6K shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest56.6K
Days to Cover1.0
% of Float1.6%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track CYCN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CYCN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for CYCN
📊 CYCN FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CYCN Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.